NO

Nick Olsen

Investor at Innovation Endeavors

San Francisco Bay Area

VC
Investor

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Research
Business Strategy
Leadership
Teamwork
Microsoft Excel
Tissue Engineering
Biomedical Engineering
Consulting
Problem Solving
Cell
Regenerative Medicine
Data Analysis
Engineering
Team Leadership
PowerPoint
Time Management
Microsoft Office
Public Speaking
Microsoft Word
Microsoft PowerPoint

Education

  • Bachelor of Science - BS

    University of Illinois at Urbana-Champaign - School of Engineering

Work Experience

Innovation Endeavors

2021

  • Principal

    2023

    investing at the intersection of technology, life sciences, and healthcare

  • Senior Associate

    2022 - 2023

  • Associate

    2021 - 2021

Exsilio Therapeutics

2024

  • Member Board of Directors

    2024

GRO Biosciences

2023 - 2024

  • Member Board of Directors

    2023 - 2024

Tempus Labs, Inc.

2018 - 2021

  • Strategy and Operations

    2018 - 2021

    Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions and deliver personalized patient care.

Bain & Company

2015 - 2018

  • Senior Associate Consultant

    2017 - 2018

  • Associate Consultant

    2015 - 2017

Spark Therapeutics, Inc.

2017 - 2017

  • Global Commercial

    2017 - 2017